Literature DB >> 24523452

Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?

Patrick Y Wen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523452      PMCID: PMC3922529          DOI: 10.1093/neuonc/nou011

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Survival in patients with glioblastoma receiving valganciclovir.

Authors:  Cecilia Söderberg-Nauclér; Afsar Rahbar; Giuseppe Stragliotto
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 2.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.

Authors:  Michael J Cannon; D Scott Schmid; Terri B Hyde
Journal:  Rev Med Virol       Date:  2010-07       Impact factor: 6.989

Review 3.  Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.

Authors:  Charles S Cobbs
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

4.  Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors:  Giuseppe Stragliotto; Afsar Rahbar; Nina Wolmer Solberg; Anders Lilja; Chato Taher; Abiel Orrego; Birgitta Bjurman; Charlotte Tammik; Petra Skarman; Inti Peredo; Cecilia Söderberg-Nauclér
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

5.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.